SINGAPORE, May 13 (Xinhua) — A Singapore life sciences company has developed a portable test-kit which can identify, from the sequence perspective, the variant strain of H1N1 virus within two hours.

   The test-kit, which named Vereflu, is a lab-on-chip application for rapid detection of all major influenza types at the point of need, the producing company Veredus Laboratories told Xinhua in a written interview recently.

   “VereFlu is a molecular diagnostic test that integrates onto a biochip both Polymerase Chain Reaction (PCR) and microarray technology.” said Daniel Floerke, the sales and marketing director for Veredus.

   Explaining the principle of the VereFlu, Floerke said, “When simplified, it is to take a throat swab from a suspected case and isolate the DNA/RNA.”


   He said that the VereFlu chip can detect, differentiate and identify not only the current H1N1 2009 strain, but various strains of influenza.

   “We can detect and differentiate for influenza A: H1, H3, H5, H7, H9 with subtypes ID’s of H1N1, H3N2, H5N1 and H9N2 and influenza B,” he said.

   He said that the integration of both PCR and microarray technology onto a biochip has increased the speed and accuracy to get an answer to several questions from one sample.